Triumph Science & Technology Co.,Ltd cancelled the acquisition of a 11% stake in Shandong Pharmaceutical Glass Co., Ltd from Shandong Luzhong Investment Co., Ltd.
July 19, 2022
Share
Triumph Science & Technology Co.,Ltd (SHSE:600552) agreed to acquire a 11% stake in Shandong Pharmaceutical Glass Co., Ltd (SHSE:600529) from Shandong Luzhong Investment Co., Ltd. for CNY 0 on August 31, 2021.
Triumph Science & Technology Co.,Ltd (SHSE:600552) cancelled the acquisition of a 11% stake in Shandong Pharmaceutical Glass Co., Ltd (SHSE:600529) from Shandong Luzhong Investment Co., Ltd. on July 19, 2022.
Triumph Science&Technology Co Ltd is a China-based company, principally engaged in electronic message display business. The Company operates in two segments. New Display segment principally provides capacitive touch screens, thin film transistor-liquid crystal display (TFT-LCD) thinning glass, TFT liquid crystal display modules (LCMs) and touch panel (TP) modules, indium tin oxide (ITO) conductive film glass and flexible coatings. The Company's products are applied in electronic information display terminal products. New Materials segment is mainly engaged in the production and sales of zirconia, spherical materials, nano-barium titanate and other materials. The Company distributes its products within domestic market and to overseas markets.
Triumph Science & Technology Co.,Ltd cancelled the acquisition of a 11% stake in Shandong Pharmaceutical Glass Co., Ltd from Shandong Luzhong Investment Co., Ltd.
TRIUMPH SCIENCE & TECHNOLOGY CO.,LTD 
